Literature DB >> 7150873

Effects of calmodulin antagonists on tension and cellular calcium content in depolarized vascular and intestinal smooth muscles.

H Karaki, K Murakami, H Nakagawa, H Ozaki, N Urakawa.   

Abstract

1 Several putative calmodulin antagonists have been examined for their inhibitory action on muscle tension and cellular Ca content in the K-depolarized vascular and intestinal smooth muscles. 2 The 65.4 mM K-induced sustained contraction in the media-intimal layer of rabbit aorta and the 45.4 mM K-induced sustained contraction in guinea-pig taenia coli were inhibited by the calmodulin antagonists, prenylamine, chlorpromazine, N2-dansyl-L-arginine-4-t-butylpiperadine amide (No. 233), and N-(6-aminohexyl)-5-chloro-1-naphthalenesulphonamide (W-7), and also by the organic Ca antagonists, verapamil and diltiazem. 3 The cellular Ca content in rabbit aorta and guinea-pig taenia coli as measured by a modified lanthanum technique increased in the high-K solutions. The increments were inhibited by these antagonists at concentrations similar to those required to inhibit the K-induced contractions. However, W-7 did not change (in aorta) or only slightly decreased (in taenia coli) the K-induced increase in the cellular Ca content. 4 A high concentration (2 X 10(-4)M) of W-7 increased the resting cellular Ca content without increasing the muscle tension in aorta. The increment was inhibited by verapamil, sodium nitroprusside or hypoxia (N2 aeration). 5 It is suggested that the inhibitory effects of prenylamine, chlorpromazine and No. 233 may be attributed mainly to the Ca antagonistic effect whereas W-7 may inhibit the process beyond the transmembrane Ca influx.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7150873      PMCID: PMC2044672          DOI: 10.1111/j.1476-5381.1982.tb09344.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Partial purification of the Ca2+-Mg2+ ATPase activator from human erythrocytes: its similarity to the activator of 3':5' - cyclic nucleotide phosphodiesterase.

Authors:  H W Jarrett; J T Penniston
Journal:  Biochem Biophys Res Commun       Date:  1977-08-22       Impact factor: 3.575

2.  Phosphodiesterase protein activator mimics red blood cell cytoplasmic activator of (Ca2+-Mg2+)ATPase.

Authors:  R M Gopinath; F F Vincenzi
Journal:  Biochem Biophys Res Commun       Date:  1977-08-22       Impact factor: 3.575

3.  Mechanism by which psychotropic drugs inhibit adenosine cyclic 3',5'-monophosphate phosphodiesterase of brain.

Authors:  R M Levin; B Weiss
Journal:  Mol Pharmacol       Date:  1976-07       Impact factor: 4.436

4.  Modulator protein as a component of the myosin light chain kinase from chicken gizzard.

Authors:  R Dabrowska; J M Sherry; D K Aromatorio; D J Hartshorne
Journal:  Biochemistry       Date:  1978-01-24       Impact factor: 3.162

5.  Possible role of endogenous catecholamines in the contractions induced in rabbit aorta by ouabain, sodium depletion and potassium depletion.

Authors:  H Karaki; N Urakawa
Journal:  Eur J Pharmacol       Date:  1977-05-01       Impact factor: 4.432

6.  The mode of contractile action of palytoxin on vascular smooth muscle.

Authors:  K Ito; H Karaki; N Urakawa
Journal:  Eur J Pharmacol       Date:  1977-11-01       Impact factor: 4.432

7.  Antagonizing action of chlorpromazine, dibenamine, and phenoxybenzamine on potassium-induced contraction.

Authors:  S Shibata; O Carrier
Journal:  Can J Physiol Pharmacol       Date:  1967-07       Impact factor: 2.273

8.  The separation of cell membrane calcium transport from extracellular calcium exchange in vascular smooth muscle.

Authors:  C Van Breemen; E McNaughton
Journal:  Biochem Biophys Res Commun       Date:  1970-05-22       Impact factor: 3.575

9.  Identification of an activator protein for myosin light chain kinase as the Ca2+-dependent modulator protein.

Authors:  K Yagi; M Yazawa; S Kakiuchi; M Ohshima; K Uenishi
Journal:  J Biol Chem       Date:  1978-03-10       Impact factor: 5.157

10.  [Uterus relaxation by highly potent Ca plus,plus-antagonistic inhibitors of electro-mechanical coupling such as Isoptin (verapamil, iproveratril), compound D 600 and Segontin (prenylamine). Experiments on the isolated virgin rat uterus].

Authors:  A Fleckenstein; G Grün; H Tritthart; K Byon
Journal:  Klin Wochenschr       Date:  1971-01
View more
  9 in total

1.  Ca2+ ion sequestration by guinea-pig tracheal cartilage: its influence on trachealis reactivity to KCl.

Authors:  P Gupta; A Markham; R M Morgan
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

2.  The inhibitory effects of N2-dansyl-L-arginine-4-t-butylpiperidine amide (TI233) on contraction of vascular and intestinal smooth muscle.

Authors:  H Karaki; K Murakami; H Nakagawa; N Urakawa
Journal:  Br J Pharmacol       Date:  1983-11       Impact factor: 8.739

3.  Changing surface charge with salicylate differentiates between subgroups of calcium-antagonists.

Authors:  M Spedding
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

4.  Divalent cation dependence of the inhibition by phenothiazines of mediator release from mast cells.

Authors:  P T Peachell; F L Pearce
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

Review 5.  Diltiazem. A review of its pharmacological properties and therapeutic efficacy.

Authors:  M Chaffman; R N Brogden
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

6.  The response of non-pregnant rat myometrium to oxytocin in Ca-free solution.

Authors:  F Ashoori; A Takai; T Tomita
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

7.  Interactions between a "calcium channel agonist", Bay K 8644, and calcium antagonists differentiate calcium antagonist subgroups in K+-depolarized smooth muscle.

Authors:  M Spedding; C Berg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-11       Impact factor: 3.000

8.  Functional interactions of calcium-antagonists in K+-depolarized smooth muscle.

Authors:  M Spedding
Journal:  Br J Pharmacol       Date:  1983-11       Impact factor: 8.739

9.  In vitro effects of calcium entry blockers, chlorpromazine and fenoterol upon human pregnant myometrium contractility.

Authors:  G Ballejo; J B Calixto; Y S Medeiros
Journal:  Br J Pharmacol       Date:  1986-11       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.